blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1078006

EP1078006 - DIAGNOSIS AND TREATMENT OF HEPATIC DISORDERS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  08.01.2010
Database last updated on 14.11.2024
Most recent event   Tooltip07.10.2011Lapse of the patent in a contracting state
New state(s): CY
published on 09.11.2011  [2011/45]
Applicant(s)For all designated states
Genentech, Inc.
1 DNA Way
South San Francisco, CA 94080-4990 / US
[N/P]
Former [2009/10]For all designated states
Genentech, Inc.
1 DNA Way
South San Francisco CA 94080-4990 / US
Former [2001/09]For all designated states
Genentech, Inc.
1 DNA Way
South San Francisco, CA 94080-4990 / US
Inventor(s)01 / FONG, Sherman
19 Basinside Way
Alameda, CA 94502 / US
02 / HILLAN, Kenneth, J.
64 Seward
San Francisco, CA 94111 / US
 [2001/09]
Representative(s)Denison, Christopher Marcus, et al
Mewburn Ellis LLP
City Tower
40 Basinghall Street
London EC2V 5DE / GB
[N/P]
Former [2001/09]Denison, Christopher Marcus, et al
Mewburn Ellis York House 23 Kingsway
GB-London WC2B 6HP / GB
Application number, filing date99922996.612.05.1999
[2001/09]
WO1999US10520
Priority number, dateUS1998007840513.05.1998         Original published format: US 78405
[2001/09]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO9958573
Date:18.11.1999
Language:EN
[1999/46]
Type: A1 Application with search report 
No.:EP1078006
Date:28.02.2001
Language:EN
The application published by WIPO in one of the EPO official languages on 18.11.1999 takes the place of the publication of the European patent application.
[2001/09]
Type: B1 Patent specification 
No.:EP1078006
Date:04.03.2009
Language:EN
[2009/10]
Search report(s)International search report - published on:EP18.11.1999
ClassificationIPC:C07K16/28, A61K38/00, A61K38/17, A61K39/395, G01N33/576, G01N33/577, C12N5/20
[2001/09]
CPC:
C07K16/2803 (EP); A61P1/16 (EP); A61P31/12 (EP);
A61P31/14 (EP); A61P31/20 (EP); A61P37/06 (EP);
C07K14/70503 (EP); C07K14/70546 (EP); C07K16/2839 (EP);
A61K38/00 (EP); C07K2319/00 (EP) (-)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [2001/09]
TitleGerman:DIAGNOSE UND BEHANDLUNG VON HEPATISCHEN KRANKHEITEN[2001/09]
English:DIAGNOSIS AND TREATMENT OF HEPATIC DISORDERS[2001/09]
French:DIAGNOSTIC ET TRAITEMENT DES TROUBLES HEPATIQUES[2001/09]
Biological materialThis application mentions deposited biological material, check the file for details
Entry into regional phase04.12.2000National basic fee paid 
04.12.2000Designation fee(s) paid 
04.12.2000Examination fee paid 
Examination procedure20.09.1999Request for preliminary examination filed
International Preliminary Examining Authority: EP
04.12.2000Examination requested  [2001/09]
13.08.2001Despatch of a communication from the examining division (Time limit: M06)
10.06.2002Reply to a communication from the examining division
03.12.2002Despatch of a communication from the examining division (Time limit: M06)
01.10.2003Reply to a communication from the examining division
02.08.2004Despatch of a communication from the examining division (Time limit: M06)
22.03.2005Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
26.05.2005Reply to a communication from the examining division
30.10.2007Despatch of a communication from the examining division (Time limit: M02)
07.01.2008Reply to a communication from the examining division
19.08.2008Communication of intention to grant the patent
22.12.2008Fee for grant paid
22.12.2008Fee for publishing/printing paid
Opposition(s)07.12.2009No opposition filed within time limit [2010/06]
Request for further processing for:22.03.2005Request for further processing filed
26.05.2005Full payment received (date of receipt of payment)
Request granted
10.06.2005Decision despatched
29.09.2003Request for further processing filed
29.09.2003Full payment received (date of receipt of payment)
Request granted
15.10.2003Decision despatched
10.06.2002Request for further processing filed
10.06.2002Full payment received (date of receipt of payment)
Request granted
25.06.2002Decision despatched
Fees paidRenewal fee
14.05.2001Renewal fee patent year 03
14.05.2002Renewal fee patent year 04
13.05.2003Renewal fee patent year 05
13.05.2004Renewal fee patent year 06
12.05.2005Renewal fee patent year 07
23.03.2006Renewal fee patent year 08
14.05.2007Renewal fee patent year 09
28.03.2008Renewal fee patent year 10
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT04.03.2009
BE04.03.2009
CY04.03.2009
FI04.03.2009
GR05.06.2009
PT18.08.2009
[2011/45]
Former [2011/25]AT04.03.2009
BE04.03.2009
FI04.03.2009
GR05.06.2009
PT18.08.2009
Former [2010/06]AT04.03.2009
BE04.03.2009
FI04.03.2009
PT18.08.2009
Cited inInternational search[XD]WO9624673  (LEUKOSITE INC [US], et al) [XD] 1-7,11-23,26-28,31-48 * page 32, line 18 - page 35, line 21 * * page 40, line 31 - page 42, line 13 * * page 67, lines 22-25 * * page 73, line 24 - page 75, line 23 *;
 [DX]WO9725351  (LEUKOSITE INC [US], et al) [DX] 1-7,11,22,23,26-28,31-34,41-45,48 * page 5, lines 1-30 * * page 25, line 27 - page 27, line 19 * * page 28, line 30 - page 29, line 8 * * page 34, lines 3-15 *;
 [A]  - TANAKA ET AL, "Inhibition of inflammatory liver injury by a monoclonal antibody against lymphocyte function-associated antigen-1", JOURNAL OF IMMUNOLOGY, (199311), vol. 151, ISSN 0022-1767, pages 5088 - 95, XP002078020 [A] 1-48 * abstract * * page 5092, column L, paragraph 2 - page 5094, column R, paragraph 1 *
 [PA]  - HILLAN, K. J. (1) ET AL, "Hepatic expression of the mucosal vascular addressin, MAdCAM -1, in hepatitis C.", MODERN PATHOLOGY, (JAN., 1999) VOL. 12, NO. 1, PP. 163A. MEETING INFO.: ANNUAL MEETING OF THE UNITED STATES AND CANADIAN ACADEMY OF PATHOLOGY SAN FRANCISCO, CALIFORNIA, USA MARCH 20-26, 1999, XP002110193 [PA] 1-48 * the whole document *
Examination   - The Leukocyte Antigen Factsbook, Academic Press San Diego, Eds. Barclay et al., pages 298-299
    - BRISKIN ET AL, "Human mucosal addressin cell adhesion molecule-1 is preferentially expressed in intestinal tract and associated lymphoid tissue", AMERICAN JOURNAL OF PATHOLOGY, (1997), vol. 151, no. 1
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.